Yves Sagot
Direktor/Vorstandsmitglied bei BIOSENIC SA
Profil
Yves Sagot was the founder of RELIEF THERAPEUTICS Holding SA, where he held the title of Chief Scientific Officer from 2016 to 2020.
He is also the founder of Sonnet BioTherapeutics CH SA. Currently, Dr. Sagot is an Independent Director at BioSenic SA since 2023.
Dr. Sagot has a graduate and doctorate degree from the University of Geneva and a doctorate degree from Université Toulouse III - Paul Sabatier.
Aktive Positionen von Yves Sagot
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOSENIC SA | Direktor/Vorstandsmitglied | 27.01.2023 |
Ehemalige bekannte Positionen von Yves Sagot
| Unternehmen | Position | Ende |
|---|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Gründer | 08.10.2020 |
Sonnet BioTherapeutics CH SA
 Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Gründer | - |
Ausbildung von Yves Sagot
| Université Toulouse III - Paul Sabatier | Doctorate Degree |
| University of Geneva | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| RELIEF THERAPEUTICS HOLDING SA | Health Technology |
| BIOSENIC SA | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Health Technology |
